These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 28805111)

  • 21. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
    Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
    Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging role of tumor microenvironment derived exosomes in therapeutic resistance and metastasis through epithelial-to-mesenchymal transition.
    Balaji S; Kim U; Muthukkaruppan V; Vanniarajan A
    Life Sci; 2021 Sep; 280():119750. PubMed ID: 34171378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparanase: From basic research to therapeutic applications in cancer and inflammation.
    Vlodavsky I; Singh P; Boyango I; Gutter-Kapon L; Elkin M; Sanderson RD; Ilan N
    Drug Resist Updat; 2016 Nov; 29():54-75. PubMed ID: 27912844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway.
    Ren D; Lin B; Zhang X; Peng Y; Ye Z; Ma Y; Liang Y; Cao L; Li X; Li R; Sun L; Liu Q; Wu J; Zhou K; Zeng J
    Oncotarget; 2017 Jul; 8(30):49807-49823. PubMed ID: 28591704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications.
    da Costa VR; Araldi RP; Vigerelli H; D'Ámelio F; Mendes TB; Gonzaga V; Policíquio B; Colozza-Gama GA; Valverde CW; Kerkis I
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of exosomes and "exosomal shuttle microRNA" in tumorigenesis and drug resistance.
    Zhao L; Liu W; Xiao J; Cao B
    Cancer Lett; 2015 Jan; 356(2 Pt B):339-46. PubMed ID: 25449429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy.
    Challagundla KB; Wise PM; Neviani P; Chava H; Murtadha M; Xu T; Kennedy R; Ivan C; Zhang X; Vannini I; Fanini F; Amadori D; Calin GA; Hadjidaniel M; Shimada H; Jong A; Seeger RC; Asgharzadeh S; Goldkorn A; Fabbri M
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25972604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art.
    Fanini F; Fabbri M
    Semin Cell Dev Biol; 2017 Jul; 67():23-28. PubMed ID: 27956165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deconstructing breast cancer cell biology and the mechanisms of multidrug resistance.
    Videira M; Reis RL; Brito MA
    Biochim Biophys Acta; 2014 Dec; 1846(2):312-25. PubMed ID: 25080053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Find new channel for overcoming chemoresistance in cancers: Role of stem cells-derived exosomal microRNAs.
    Hussein GM; Mohammed SM; Faris M; Mohammed A; Kadhim MJ; Awadh SA; Ajam WH; Jalil AT
    Int J Biol Macromol; 2022 Oct; 219():530-537. PubMed ID: 35948201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine-mediated therapeutic resistance in breast cancer.
    Tan C; Hu W; He Y; Zhang Y; Zhang G; Xu Y; Tang J
    Cytokine; 2018 Aug; 108():151-159. PubMed ID: 29609137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance.
    Mashouri L; Yousefi H; Aref AR; Ahadi AM; Molaei F; Alahari SK
    Mol Cancer; 2019 Apr; 18(1):75. PubMed ID: 30940145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of exosomes in transferring chemoresistance through modulation of cancer glycolytic cell metabolism.
    Vahabi M; Comandatore A; Franczak MA; Smolenski RT; Peters GJ; Morelli L; Giovannetti E
    Cytokine Growth Factor Rev; 2023 Oct; 73():163-172. PubMed ID: 37541790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression.
    Corcoran C; Rani S; O'Driscoll L
    Prostate; 2014 Sep; 74(13):1320-34. PubMed ID: 25053345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical role of HMGA proteins in cancer cell chemoresistance.
    D'Angelo D; Mussnich P; Arra C; Battista S; Fusco A
    J Mol Med (Berl); 2017 Apr; 95(4):353-360. PubMed ID: 28293697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
    Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
    Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosomes and cancer: From oncogenic roles to therapeutic applications.
    Mohammadi S; Yousefi F; Shabaninejad Z; Movahedpour A; Mahjoubin Tehran M; Shafiee A; Moradizarmehri S; Hajighadimi S; Savardashtaki A; Mirzaei H
    IUBMB Life; 2020 Apr; 72(4):724-748. PubMed ID: 31618516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA Regulation of Energy Metabolism to Induce Chemoresistance in Cancers.
    Ye J; Zou M; Li P; Liu H
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818805997. PubMed ID: 30444190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
    Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
    Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.